Premium
Anthem Biosciences Pvt Ltd, a Bengaluru-based contract drug researcher and manufacturer, is contemplating an initial public offering (IPO) in India that could raise about $400 million (Rs 3340 crore), a media report said. VCCircle first reported that Anthem is looking to snag $50-70 million in fresh funding as it gears up for an IPO. Indian private equity ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
